AR077844A1 - Metodos, cebadores, sondas y conjuntos de elementos para detectar mutaciones braf - Google Patents
Metodos, cebadores, sondas y conjuntos de elementos para detectar mutaciones brafInfo
- Publication number
- AR077844A1 AR077844A1 ARP100102935A ARP100102935A AR077844A1 AR 077844 A1 AR077844 A1 AR 077844A1 AR P100102935 A ARP100102935 A AR P100102935A AR P100102935 A ARP100102935 A AR P100102935A AR 077844 A1 AR077844 A1 AR 077844A1
- Authority
- AR
- Argentina
- Prior art keywords
- braf
- seq
- sample
- sequence
- mutant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Paints Or Removers (AREA)
Abstract
Métodos, cebadores y sondas de utilidad para detectar la presencia de secuencias BRAF mutantes en una muestra, específicamente para detectar la presencia de las mutaciones BRAF V600E, V600D, V600K y V600M, por lo que es posible usarlas para diagnosticar diversos canceres. Reivindicacion 1: Un método para detectar la presencia de una mutacion BRAF en una muestra, caracterizado porque comprende (a) aislar un ácido nucleico de dicha muestra, donde la muestra comprende secuencias de ADN; (b) realizar una reaccion de amplificacion con las secuencias de ADN de dicha muestra, donde dicha reaccion de amplificacion comprende un primer cebador capaz de alinearse específicamente con una secuencia BRAF mutante en una primera posicion en una secuencia de AUN BRAF, donde dicho primer cebador es SEQ ID Ns 1, SEQ ID Ns 2, SEQ ID Ns 3, SEQ ID Ns 4, SEQ ID Ns 5, SEQ ID Ns 6, SEQ ID Ns 7, SEQ ID Ns 8 o SEQ ID Ns 9, y un segundo cebador capaz de alinearse específicamente en una segunda posicion en una secuencia de ADN BRAF, donde dichos cebadores, el primero y el segundo, se alinean con las distintas cadenas de la secuencia de ADN BRAF de cadena doble, donde la reaccion de amplificacion permite generar un producto de amplificacion específico para BRAF mutante cuando las secuencias de ADN de la muestra comprenden una secuencia de ADN BRAF que comprende una secuencia mutante en dicha primera posicion de dicha secuencia de AUN BRAF; y (c) visualizar los productos de amplificacion generados en dicha reaccion de amplificacion, donde la deteccion de un producto de amplificacion especifico para BRAF mutante es un indicador positivo de una mutacion BRAF en dicha muestra.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23305409P | 2009-08-11 | 2009-08-11 | |
| US23707809P | 2009-08-26 | 2009-08-26 | |
| US30179010P | 2010-02-05 | 2010-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR077844A1 true AR077844A1 (es) | 2011-09-28 |
Family
ID=43586772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100102935A AR077844A1 (es) | 2009-08-11 | 2010-08-11 | Metodos, cebadores, sondas y conjuntos de elementos para detectar mutaciones braf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20140248614A1 (es) |
| EP (1) | EP2464751B1 (es) |
| JP (1) | JP2013501523A (es) |
| KR (1) | KR20120099630A (es) |
| CN (1) | CN102575295B (es) |
| AR (1) | AR077844A1 (es) |
| AU (1) | AU2010282632A1 (es) |
| CA (1) | CA2770716A1 (es) |
| HK (1) | HK1172931A1 (es) |
| IL (1) | IL218021A0 (es) |
| NZ (1) | NZ598166A (es) |
| TW (1) | TW201111517A (es) |
| WO (1) | WO2011019704A2 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6153758B2 (ja) * | 2012-04-20 | 2017-06-28 | アークレイ株式会社 | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用キット |
| US10077474B2 (en) | 2012-05-29 | 2018-09-18 | Abbott Molecular, Inc. | Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits |
| CN102816851A (zh) * | 2012-08-29 | 2012-12-12 | 苏州旷远生物分子技术有限公司 | 用于检测braf基因v600e突变的引物、探针、试剂盒及方法 |
| CN102876784B (zh) * | 2012-09-13 | 2014-11-19 | 周宏灏 | 焦磷酸测序法检测B-raf基因多态性的试剂盒及方法 |
| EP2711432A1 (en) * | 2012-09-21 | 2014-03-26 | Genomica S.A.U. | Method for detection of BRAF and PI3K mutations |
| CA3077539C (en) * | 2012-12-27 | 2023-09-12 | Quest Diagnostics Investments Incorporated | Ddr2 mutations as targetable features of melanoma or basal cell carcinoma |
| CN103103269B (zh) * | 2013-01-18 | 2015-07-15 | 陕西佰美基因股份有限公司 | 一种基于探针熔解技术准确检测braf基因突变的方法 |
| JP2016512041A (ja) * | 2013-03-15 | 2016-04-25 | アボツト・モレキユラー・インコーポレイテツド | 多重対立遺伝子の検出 |
| KR101378920B1 (ko) * | 2013-04-18 | 2014-03-27 | 주식회사 현일바이오 | Ｂｒａｆ 돌연변이의 선택적 검출 방법 및 이를 이용한 키트 |
| CN105705655A (zh) * | 2013-08-14 | 2016-06-22 | 佳根曼斯菲尔德有限公司 | 用于对nras和braf核酸进行多重分析的组合物及方法 |
| CN104017887A (zh) * | 2014-06-18 | 2014-09-03 | 广州好芝生物科技有限公司 | 人类braf基因突变检测引物对和探针及其试剂盒 |
| KR20190095523A (ko) * | 2014-07-11 | 2019-08-14 | 익스프레션 패톨로지, 인크. | 세린/트레오닌-단백질 키나제 수용체 B-raf(BRAF)에 대한 SRM/MRM 검정 |
| CN105400900A (zh) * | 2015-12-29 | 2016-03-16 | 杭州迪安生物技术有限公司 | 焦磷酸测序技术检测braf基因v600e微量突变试剂盒及其应用 |
| CN105861691A (zh) * | 2016-05-06 | 2016-08-17 | 北京晋祺生物科技有限公司 | 一种braf基因突变检测的引物组合物、试剂盒及方法 |
| US20200360537A1 (en) * | 2017-06-29 | 2020-11-19 | Korea Advanced Institute Of Science And Technology | A ganglioglioma-induced animal model and a method for diagnosing and treating ganglioglioma and related diseases |
| KR20190038464A (ko) * | 2017-09-29 | 2019-04-08 | (재)록원바이오융합연구재단 | Ras/braf 돌연변이 검출용 조성물 및 이를 포함하는 키트 |
| CN109161594A (zh) * | 2018-08-17 | 2019-01-08 | 中山大学达安基因股份有限公司 | 一种检测braf基因突变的方法及其试剂盒 |
| KR20220079492A (ko) * | 2020-12-04 | 2022-06-13 | 주식회사 제노픽스 | 폐암 유전자 돌연변이 초고감도 선택적 증폭 방법 및 이를 위한 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004337120A (ja) * | 2003-05-19 | 2004-12-02 | Chang Gung Univ | 膀胱癌再発検査方法 |
| US7745125B2 (en) * | 2004-06-28 | 2010-06-29 | Roche Molecular Systems, Inc. | 2′-terminator related pyrophosphorolysis activated polymerization |
| CN101487051B (zh) * | 2009-02-24 | 2011-07-20 | 广州益善生物技术有限公司 | Braf基因突变的检测探针、液相芯片及其检测方法 |
-
2010
- 2010-08-10 EP EP10808619.0A patent/EP2464751B1/en not_active Not-in-force
- 2010-08-10 CA CA2770716A patent/CA2770716A1/en not_active Abandoned
- 2010-08-10 AU AU2010282632A patent/AU2010282632A1/en not_active Abandoned
- 2010-08-10 KR KR1020127004699A patent/KR20120099630A/ko not_active Application Discontinuation
- 2010-08-10 NZ NZ598166A patent/NZ598166A/en not_active IP Right Cessation
- 2010-08-10 CN CN201080045765.7A patent/CN102575295B/zh not_active Expired - Fee Related
- 2010-08-10 JP JP2012524782A patent/JP2013501523A/ja active Pending
- 2010-08-10 WO PCT/US2010/044997 patent/WO2011019704A2/en active Application Filing
- 2010-08-11 TW TW099126740A patent/TW201111517A/zh unknown
- 2010-08-11 AR ARP100102935A patent/AR077844A1/es unknown
-
2012
- 2012-02-09 IL IL218021A patent/IL218021A0/en unknown
-
2013
- 2013-01-04 HK HK13100094.0A patent/HK1172931A1/zh not_active IP Right Cessation
-
2014
- 2014-02-27 US US14/192,414 patent/US20140248614A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013501523A (ja) | 2013-01-17 |
| TW201111517A (en) | 2011-04-01 |
| WO2011019704A2 (en) | 2011-02-17 |
| HK1172931A1 (zh) | 2013-05-03 |
| EP2464751B1 (en) | 2017-05-24 |
| EP2464751A4 (en) | 2013-07-03 |
| EP2464751A2 (en) | 2012-06-20 |
| AU2010282632A1 (en) | 2012-03-08 |
| IL218021A0 (en) | 2012-04-30 |
| CN102575295B (zh) | 2016-02-17 |
| US20140248614A1 (en) | 2014-09-04 |
| CA2770716A1 (en) | 2011-02-17 |
| WO2011019704A3 (en) | 2011-07-07 |
| KR20120099630A (ko) | 2012-09-11 |
| NZ598166A (en) | 2014-03-28 |
| CN102575295A (zh) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR077844A1 (es) | Metodos, cebadores, sondas y conjuntos de elementos para detectar mutaciones braf | |
| ATE534753T1 (de) | Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens | |
| NZ616407A (en) | Method and product for localised or spatial detection of nucleic acid in a tissue sample | |
| JP2013063072A5 (es) | ||
| JP2014500729A5 (es) | ||
| JP2009077712A5 (es) | ||
| NZ594751A (en) | Method of diagnosis of infection by mycobacteria and reagents therefor | |
| CO6260156A2 (es) | Cebadores y sendas para la detecciondel estado de metilacion de un gen, incluyendo el gen mage-a3 | |
| MX2014005302A (es) | Amplia deteccion de los serotipos del virus de dengue. | |
| WO2009057829A3 (en) | Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus | |
| WO2008127921A3 (en) | Primer and probe sequences for detecting chlamydia trachomatis | |
| JP2014530011A5 (es) | ||
| EP2589667A4 (en) | HIGHLY SENSITIVE DETECTION PROCEDURE OF MUTATED GENES | |
| WO2011148269A3 (en) | Differentiation of species within the mycobacterium tuberculosis complex | |
| WO2009085704A3 (en) | Compositions and methods to detect candida albicans nucleic acid | |
| BR112017001500A2 (pt) | composições e métodos para a detecção e análise de tuberculose por micobactéria | |
| AU2018250570A1 (en) | Methods for multiplex detection of alleles associated with corneal dystrophy | |
| WO2015127201A8 (en) | Hiv-2 nucleic acids and methods of detection | |
| ES2640570T3 (es) | Ensayo de doble sonda para la detección de VHC | |
| EP3342876A3 (en) | Methods for detecting gastrointestinal pathogen nucleic acid | |
| JP2017143810A5 (es) | ||
| WO2011114142A3 (en) | Sequence detection assay | |
| WO2012103353A3 (en) | Selective detection of haemophilus influenzae | |
| AR080913A1 (es) | Cebadores, sondas, metodos y conjuntos de elementos para la deteccion de variantes de eml4- alk | |
| WO2012112884A3 (en) | Real-time pcr point mutation assays for detecting hiv - 1 resistance to antiviral drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |